These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 21237297)

  • 21. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
    Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
    Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer biomarker development and two-dimensional difference gel electrophoresis (2D-DIGE).
    Kondo T
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):2-8. PubMed ID: 30392560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2D-DIGE Analysis of Liver Disease in Mice.
    Callebaut A; Derua R; Overbergh L; Janssens V
    Methods Mol Biol; 2023; 2596():231-244. PubMed ID: 36378443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
    Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP
    J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
    Zhang W; Ou X; Wu X
    Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sub-proteome differential display: single gel comparison by 2D electrophoresis and mass spectrometry.
    Spandidos A; Rabbitts TH
    J Mol Biol; 2002 Apr; 318(1):21-31. PubMed ID: 12054765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.
    Zhu Y; Cai L; Guo J; Chen N; Yi X; Zhao Y; Cai J; Wang Z
    Tumour Biol; 2016 Oct; 37(10):14009-14023. PubMed ID: 27492604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein expression changes in ovarian cancer during the transition from benign to malignant.
    Waldemarson S; Krogh M; Alaiya A; Kirik U; Schedvins K; Auer G; Hansson KM; Ossola R; Aebersold R; Lee H; Malmström J; James P
    J Proteome Res; 2012 May; 11(5):2876-89. PubMed ID: 22471520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
    Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
    Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
    Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search for a diagnostic/prognostic biomarker for the brain cancer glioblastoma multiforme by 2D-DIGE-MS technique.
    Banerjee HN; Mahaffey K; Riddick E; Banerjee A; Bhowmik N; Patra M
    Mol Cell Biochem; 2012 Aug; 367(1-2):59-63. PubMed ID: 22547198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and validation of salivary proteomic signatures for non-invasive detection of ovarian cancer.
    Tajmul M; Parween F; Singh L; Mathur SR; Sharma JB; Kumar S; Sharma DN; Yadav S
    Int J Biol Macromol; 2018 Mar; 108():503-514. PubMed ID: 29222021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches.
    Silsirivanit A; Sawanyawisuth K; Riggins GJ; Wongkham C
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):388-96. PubMed ID: 24616382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation.
    Hoskins ER; Hood BL; Sun M; Krivak TC; Edwards RP; Conrads TP
    PLoS One; 2011; 6(9):e25056. PubMed ID: 21980378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma proteomic pattern as biomarkers for ovarian cancer.
    Lin YW; Lin CY; Lai HC; Chiou JY; Chang CC; Yu MH; Chu TY
    Int J Gynecol Cancer; 2006; 16 Suppl 1():139-46. PubMed ID: 16515582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.
    Ummanni R; Mundt F; Pospisil H; Venz S; Scharf C; Barett C; Fälth M; Köllermann J; Walther R; Schlomm T; Sauter G; Bokemeyer C; Sültmann H; Schuppert A; Brümmendorf TH; Balabanov S
    PLoS One; 2011 Feb; 6(2):e16833. PubMed ID: 21347291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).
    Hariharan D; Weeks ME; Crnogorac-Jurcevic T
    Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential gel-based proteomic approach for cancer biomarker discovery using human plasma.
    Na K; Lee MJ; Jeong HJ; Kim H; Paik YK
    Methods Mol Biol; 2012; 854():223-37. PubMed ID: 22311764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.